Welcome to MOLLI Surgical’s media kit for our latest products: MOLLI 2® and MOLLI re.markable™. These latest products, including the industry’s first tool that ensures lesions are accurately marked, are paving the way for the next generation of healthcare. They deliver on the company’s commitment to elevate the patient experience, refine precision surgery, and boost physicians’ confidence.
MOLLI 2 is an evolution in MOLLI Surgical’s award-winning lesion localization platform technology. Now more precise than ever, we have incorporated NEW directional feedback into our Wand and Tablet display making it even more simple and intuitive.
MOLLI re.markable is a revolutionary new tool helping physicians accurately mark lesions by allowing radiologists and surgeons to reposition a localization marker with minimal impact or discomfort for patients. If the original placement was suboptimal, the localization marker can be removed without requiring invasive surgery or a large biopsy needle. This is a first of its kind, as no other localization marker on the market can be removed like this.
Ananth Ravi
President & CEO, Co-founder
Throughout his career, Ananth has sought to improve the patient experience. He is the only medical physicist ever to win the Human Touch Award, which recognizes a passion for improving the quality of care for cancer patients within Ontario.
Ananth has a history of peer-reviewed research focused on improving image guidance for medical procedures ranging from radiation to surgical oncology techniques. His primary focus has been on making precision surgery simpler through targeted innovation and increasing access to high-quality care. Ananth is a co-inventor on numerous patents and has garnered several grants for medical device innovations.
Ananth’s commitment to improving the treatment process for patients inspired him to develop the magnetic tracking technology that resulted in the creation of MOLLI Surgical. Prior to co-founding the company, he was a certified medical physicist at Sunnybrook Odette Cancer Centre and clinical operations lead, brachytherapy. Under Ananth’s leadership, Sunnybrook’s brachytherapy program became one of the highest performing in the world. Ananth completed his doctoral studies at the University of Toronto. He has held faculty appointments at Sunnybrook Research Institute, the University of Toronto, and Toronto Metropolitan University.
John Dillon
Chief Technology Officer, Co-founder
John leads the product development and manufacturing teams at MOLLI Surgical. He has over a decade of experience in developing high-performing technologies and quality initiatives in the medical sector.
John was inspired to co-invent the MOLLI device while working at Sunnybrook Health Sciences Centre, where he developed and managed the x-ray safety program and advanced radiation safety and oncology research. Seeking a way to improve the localization experience for breast cancer patients, John and his colleagues utilized magnets, a wand, and computer tablet to create what eventually became the flagship product.
John is a graduate of Ryerson University with a B.Sc. in medical physics. He is a two-time recipient of the Harold E. Johns Award in medical physics.
In addition to developing medical devices, John’s passion for innovation and leadership has led to his involvement in designing, manufacturing, and racing sailboats and formula cars. He continues to be active in sailboat racing at the local and international level.
Diana Chan
Chief Marketing Officer
Diana is a medical device executive with over 20 years of experience in sales, marketing and strategic development. She specializes in building and leading synergistic teams and has a proven track record of developing innovative solutions within healthcare environments.
Diana has broad market experience, having founded BridgeGap Solutions Group to provide business and market development support to organizations with limited resources, in addition to holding previous executive positions at Medtronic, Bard and Fresenius Medical Care. She has been recognized as one of the Top Women in Marketing by PR Daily.
Diana is passionate about giving back to the community and has participated in several fundraising initiatives to promote awareness and action. An avid athlete, she has participated in the Princess Margaret Ride to Conquer Cancer, CIBC Run for the Cure and triathlons for the Shad Ireland Dialysis Foundation. She is a proud alumnus of the University of Notre Dame and strives to “Play like a Champion” every day.
Paul Radchuck
Chief Financial Officer
Paul is responsible for leading alignment of our business, operations and financial strategy to support our short- and long-term growth objectives. He has an extensive investment banking background developed at top financial advisory firms, serving clients at large cap and small/private companies.
Before joining MOLLI, Paul served as Vice President at Lazard, the world’s largest independent investment bank, where he specialized in transaction execution and cross-border mandates involving acquisitions, divestitures, and liability management. Prior to that, he was a Vice President at Morgan Stanley in their Investment Banking Division.
Paul has an MBA from the Rotman School of Management, University of Toronto. He earned an undergraduate degree in electrical engineering from Dalhousie University and began his career as an engineer at Halliburton.
Paul is passionate about helping others, and is proudly involved in the SickKids Foundation – SickKids Innovator Program.
Ananth and John with TIME’s Best Inventions of 2022 and Fast Company’s Next Big Things in Tech Awards
